Efficacy and Safety of Sirolimus in COVID-19 Infection
NCT04461340
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
COVID 19
Interventions
DRUG:
Sirolimus
Sponsor
Alexandria University